(Q85096433)

English

ER, PgR, HER-2, Ki-67, topoisomerase IIα, and nm23-H1 proteins expression as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer

scientific article published on 25 September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872186%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

ER, PgR, HER-2, Ki-67, topoisomerase IIα, and nm23-H1 proteins expression as predictors of pathological complete response to neoadjuvant chemotherapy for locally advanced breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872186%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Xi-ru Li

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872186%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Mei Liu

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872186%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Yan-jun Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872186%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Jian-dong Wang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872186%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Yi-qiong Zheng

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872186%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Jie Li

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872186%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Bing Ma

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872186%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Xin Song

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872186%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

25 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872186%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872186%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

28 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872186%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

S48-54

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20872186%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

https://scigraph.springernature.com/pub.10.1007/s12032-010-9693-y

0 references

Amplification and overexpression of topoisomerase IIalpha predict response to anthracycline-based therapy in locally advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gene expression profiling of breast cancer patients treated with docetaxel, doxorubicin, and cyclophosphamide within the GEPARTRIO trial: HER-2, but not topoisomerase II alpha and microtubule-associated protein tau, is highly predictive of tumor res

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary chemotherapy in locally advanced breast cancer (LABC): effects on tumour proliferative activity, bcl-2 expression and the relationship between tumour regression and biological markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of ER and Ki-67 proliferation index as prognostic factors for survival following neoadjuvant chemotherapy with doxorubicin/docetaxel for locally advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topoisomerase IIα gene status and prediction of pathological complete remission after anthracycline-based neoadjuvant chemotherapy in endocrine non-responsive Her2/neu-positive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2, p53, p21 and hormonal receptors proteins expression as predictive factors of response and prognosis in locally advanced breast cancer treated with neoadjuvant docetaxel plus epirubicin combination

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2 and topo-isomerase IIalpha as predictive markers in a population of node-positive breast cancer patients randomly treated with adjuvant CMF or epirubicin plus cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of response to primary chemotherapy for operable breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

nm23 in ovarian cancer: correlation with clinical outcome and other clinicopathologic and biochemical prognostic parameters

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proliferation markers predictive of the pathological response and disease outcome of patients with breast carcinomas treated by anthracycline-based preoperative chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Utilizing prognostic and predictive factors in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER2 status and efficacy of adjuvant anthracyclines in early breast cancer: a pooled analysis of randomized trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The potential biomarkers in predicting pathologic response of breast cancer to three different chemotherapy regimens: a case control study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specificity of HercepTest in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive markers of response to neoadjuvant chemotherapy in breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of response to therapy in advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Signal transduction pathways of taxanes-induced apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA topoisomerase IIalpha expression and the response toprimary chemotherapy in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Downregulation of intracellular nm23-H1 prevents cisplatin-induced DNA damage in oesophageal cancer cells: possible association with Na(+), K(+)-ATPase

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protein Markers in Colorectal Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II neoadjuvant trial of sequential nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil/epirubicin/cyclophosphamide in locally advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/20872186

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85096433&oldid=1755838093"